Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Methods in Molecular Biology (Clifton, N.J.)|October 9, 2016
QS-21 Adjuvant: Laboratory-Scale Purification Method and Formulation Into LiposomesLivia Brunner, Christophe Barnier-Quer, Nicolas Collin
Nanomaterials (Basel, Switzerland)|March 29, 2017
Nanocarriers for DNA Vaccines: Co-Delivery of TLR-9 and NLR-2 Ligands Leads to Synergistic Enhancement of Proinflammatory Cytokine ReleaseJohanna Poecheim, Simon Heuking, Livia Brunner, et al.
Biochemistry|May 23, 2002
Intrinsic lipid preferences and kinetic mechanism of Escherichia coli MurGLan Chen, Hongbin Men, Sha Ha, et al.
Vaccine|August 14, 2012
Technology transfer of an oil-in-water vaccine-adjuvant for strengthening pandemic influenza preparedness in IndonesiaRoland Ventura, Livia Brunner, Bambang Heriyanto, et al.
Therapeutic Advances in Vaccines|May 19, 2017
Accounting for adjuvant-induced artifacts in the characterization of vaccine formulations by polyacrylamide gel electrophoresisVirginie Jakob, Livia Brunner, Christophe Barnier-Quer, et al.
The Journal of Biological Chemistry|March 29, 2003
Lipid II is an intrinsic component of the pore induced by nisin in bacterial membranesEefjan Breukink, Hester E van Heusden, Pauline J Vollmerhaus, et al.
BMC Immunology|February 2, 2018
Down selecting adjuvanted vaccine formulations: a comparative method for harmonized evaluationSumera Y Younis, Christophe Barnier-Quer, Simon Heuking, et al.
Frontiers in Cellular and Infection Microbiology|July 5, 2022
Designing Adjuvant Formulations to Promote Immunogenicity and Protective Efficacy of Leptospira Immunoglobulin-Like Protein A Subunit VaccineTeerasit Techawiwattanaboon, Thomas Courant, Livia Brunner, et al.
Frontiers in Cellular and Infection Microbiology|September 3, 2025
Correction: Designing adjuvant formulations to promote immunogenicity and protective efficacy of Leptospira immunoglobulin-like protein a subunit vaccineTeerasit Techawiwattanaboon, Thomas Courant, Livia Brunner, et al.
Mbio|March 12, 2020
Vaccine-Induced Th1-Type Response Protects against Invasive Group A Streptococcus Infection in the Absence of Opsonizing AntibodiesTania Rivera-Hernandez, Mira Syahira Rhyme, Amanda J Cork, et al.
Pageof 2